enVVeno Medical Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Public

  • Employees
  • 31

Employees

  • Stock Symbol
  • NVNO

Stock Symbol

  • Share Price
  • $5.01
  • (As of Friday Closing)

enVVeno Medical General Information

Description

enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).

Contact Information

Website
www.envveno.com
Formerly Known As
Hancock Jaffe Laboratories
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Therapeutic Devices
Stock Exchange
NAS
Corporate Office
  • 70 Doppler
  • Irvine, CA 92618
  • United States
+1 (949) 000-0000

enVVeno Medical Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

enVVeno Medical Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.01 $4.93 $2.51 - $6.97 $66.8M 13.3M 108K -$1.66

enVVeno Medical Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 27,434 44,230 9,769 4,832
Revenue 0 0 0 0
EBITDA (21,759) (23,150) (24,305) (16,094)
Net Income (22,116) (23,516) (24,669) (16,528)
Total Assets 44,829 48,635 41,661 57,699
Total Debt 1,317 1,402 1,716 2,006
Public Fundamental Data provided by Morningstar, Inc. disclaimer

enVVeno Medical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore enVVeno Medical‘s full profile, request access.

Request a free trial

enVVeno Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to i
Therapeutic Devices
Irvine, CA
31 As of 2023
00000
000000000 00000

000000

olore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident,
00000000000 0000000
Irvine, CA
000 As of 0000
0000
0000000000.

000000

ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor
00000000000 0000000
Irvine, CA
000 As of 0000
00000
00.00 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

enVVeno Medical Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Endologix Corporation Irvine, CA 000 0000 0000000000.
Axonics Formerly VC-backed Irvine, CA 000 00000 000000&0 00000
Carmat Formerly PE-Backed Velizy Villacoublay, France 000 00000 0000000000 00000
Boston Scientific Corporation Marlborough, MA 00000 000.00 000000000 00 000.00
Abiomed Corporate Backed or Acquired Danvers, MA 0000 000.00 000000&0 000.00
You’re viewing 5 of 18 competitors. Get the full list »

enVVeno Medical Patents

enVVeno Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230363901-A1 Transcatheter valve for venous insufficiency Pending 11-May-2022 0000000000
US-20230363914-A1 Transcatheter vein frame for venous insufficiency Pending 11-May-2022 0000000000
US-20230363900-A1 Transcatheter valve system and method for venous insufficiency Pending 11-May-2022 0000000000
US-20220118158-A1 Bioprosthetic graft for coronary artery bypass grafting Pending 21-Oct-2020 0000000000
EP-4115853-A1 Implantable vein frame Active 15-Nov-2016 A61F2/2418 0
To view enVVeno Medical’s complete patent history, request access »

enVVeno Medical Executive Team (12)

Name Title Board Seat Contact Info
Robert Berman JD Chief Executive Officer & Board Member
Craig Glynn Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Andrew Cormack Chief COmmercial Officer
Marc Glickman MD Chief Medical Officer & Senior Vice President
You’re viewing 4 of 12 executive team members. Get the full list »

enVVeno Medical Board Members (4)

Name Representing Role Since
000000 000000 00 enVVeno Medical Chief Executive Officer & Board Member 000 0000
You’re viewing 1 of 4 board members. Get the full list »

enVVeno Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

enVVeno Medical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore enVVeno Medical‘s full profile, request access.

Request a free trial

enVVeno Medical FAQs

  • When was enVVeno Medical founded?

    enVVeno Medical was founded in 1999.

  • Who is the founder of enVVeno Medical?

    Norman Jaffe Ph.D and Warren Hancock are the founders of enVVeno Medical.

  • Who is the CEO of enVVeno Medical?

    Robert Berman JD is the CEO of enVVeno Medical.

  • Where is enVVeno Medical headquartered?

    enVVeno Medical is headquartered in Irvine, CA.

  • What is the size of enVVeno Medical?

    enVVeno Medical has 31 total employees.

  • What industry is enVVeno Medical in?

    enVVeno Medical’s primary industry is Therapeutic Devices.

  • Is enVVeno Medical a private or public company?

    enVVeno Medical is a Public company.

  • What is enVVeno Medical’s stock symbol?

    The ticker symbol for enVVeno Medical is NVNO.

  • What is the current stock price of enVVeno Medical?

    As of 24-May-2024 the stock price of enVVeno Medical is $5.01.

  • What is the current market cap of enVVeno Medical?

    The current market capitalization of enVVeno Medical is $66.8M.

  • Who are enVVeno Medical’s competitors?

    Endologix, Axonics, Carmat, Boston Scientific, and Abiomed are some of the 18 competitors of enVVeno Medical.

  • What is enVVeno Medical’s annual earnings per share (EPS)?

    enVVeno Medical’s EPS for 12 months was -$1.66.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »